Literature DB >> 23024497

An ophthalmologist survey-based study of the atypical presentations and current treatment practices of ocular toxoplasmosis in India.

Soumyava Basu1, Jyotirmay Biswas, Uwe Pleyer, Avinash Pathangay, B Manohar Babu.   

Abstract

The last two decades have seen a paradigm shift in the understanding of ocular toxoplasmosis. Post-natally acquired infection with its atypical presentations, has emerged as a common form of the disease. We conducted a questionnaire-based survey to investigate the characteristics of atypical presentations and current treatment practices of ocular toxoplasmosis, in India. A written questionnaire was distributed to ophthalmologists at two major uveitis meetings, held in Hyderabad, India in January, 2009. It evaluated characteristics of atypical presentations of ocular toxoplasmosis and specific treatment-related issues in India. Of 37 respondents who completed the questionnaire, 28 (75.6%) found atypical presentations in less than one-fourth of ocular toxoplasmosis patients. Atypical presentations were mostly seen as primary retinitis lesion, and in healthy immuno-competent individuals. Most ophthalmologists (n = 28, 75.6%) thought viral retinitis to be the most common differential diagnosis for atypical ocular toxoplasmosis and relied on serological tests (n = 19, 51.3%) for the diagnosis. Twenty-three (62.1%) respondents treated all patients with active lesions. A diverse range of treatment regimens were used, trimethoprim-sulphamethoxazole combination being most common (n = 12, 32.4%). Corticosteroids were included in all regimens. Atypical presentations of ocular toxoplasmosis were identified by all ophthalmologists, participating in the survey, though not commonly by most. Treatment practices were diverse, reflecting the lack of consensus on this issue.

Entities:  

Keywords:  Atypical; Ocular; Survey; Toxoplasmosis; Treatment

Year:  2011        PMID: 23024497      PMCID: PMC3235369          DOI: 10.1007/s12639-011-0037-4

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  26 in total

1.  Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families.

Authors:  C Silveira; R Belfort; M Burnier; R Nussenblatt
Journal:  Am J Ophthalmol       Date:  1988-09-15       Impact factor: 5.258

2.  Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome.

Authors:  G N Holland; R E Engstrom; B J Glasgow; B B Berger; S A Daniels; Y Sidikaro; J A Harmon; D H Fischer; D S Boyer; N A Rao
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

3.  Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.

Authors:  Masoud Soheilian; Mohammad-Mehdi Sadoughi; Mehdi Ghajarnia; Mohammad H Dehghan; Shahin Yazdani; Hassan Behboudi; Arash Anisian; Gholam A Peyman
Journal:  Ophthalmology       Date:  2005-09-19       Impact factor: 12.079

4.  Atypical, severe toxoplasmic retinochoroiditis in elderly patients.

Authors:  M W Johnson; G M Greven; G J Jaffe; H Sudhalkar; A K Vine
Journal:  Ophthalmology       Date:  1997-01       Impact factor: 12.079

5.  Current practices in the management of ocular toxoplasmosis.

Authors:  R E Engstrom; G N Holland; R B Nussenblatt; D A Jabs
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

6.  Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features.

Authors:  Christine Fardeau; Stéphane Romand; Narsing A Rao; Nathalie Cassoux; Olivier Bettembourg; Philippe Thulliez; Phuc Lehoang
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

8.  An update on current practices in the management of ocular toxoplasmosis.

Authors:  Gary N Holland; Kevan G Lewis
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

9.  Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis.

Authors:  Emmanuelle Delair; Dominique Monnet; Sophie Grabar; Jean Dupouy-Camet; Hélène Yera; Antoine P Brézin
Journal:  Am J Ophthalmol       Date:  2008-08-23       Impact factor: 5.258

10.  Presumed acquired ocular toxoplasmosis.

Authors:  M J Ronday; L Luyendijk; G S Baarsma; J G Bollemeijer; A Van der Lelij; A Rothova
Journal:  Arch Ophthalmol       Date:  1995-12
View more
  3 in total

1.  Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.

Authors:  William B Yates; Fabian Chiong; Sophia Zagora; Jeffrey J Post; Denis Wakefield; Peter McCluskey
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Jul-Aug

Review 2.  A systematic approach to emergencies in uveitis.

Authors:  Hassan A Al-Dhibi; Ammar M Al-Mahmood; J Fernando Arevalo
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Jul-Sep

Review 3.  Water related ocular diseases.

Authors:  Syed Shoeb Ahmad
Journal:  Saudi J Ophthalmol       Date:  2017-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.